Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Prepaid Assets (2020 - 2025)

Historic Prepaid Assets for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to $2.6 million.

  • Foghorn Therapeutics' Prepaid Assets fell 3252.54% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 3252.54%. This contributed to the annual value of $5.9 million for FY2024, which is 440.89% down from last year.
  • Per Foghorn Therapeutics' latest filing, its Prepaid Assets stood at $2.6 million for Q3 2025, which was down 3252.54% from $3.9 million recorded in Q2 2025.
  • Foghorn Therapeutics' 5-year Prepaid Assets high stood at $6.2 million for Q2 2023, and its period low was $2.6 million during Q3 2025.
  • In the last 5 years, Foghorn Therapeutics' Prepaid Assets had a median value of $4.8 million in 2025 and averaged $4.7 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first skyrocketed by 5701.68% in 2022, then plummeted by 3252.54% in 2025.
  • Foghorn Therapeutics' Prepaid Assets (Quarter) stood at $5.3 million in 2021, then rose by 6.22% to $5.6 million in 2022, then rose by 9.34% to $6.1 million in 2023, then fell by 4.41% to $5.9 million in 2024, then tumbled by 55.77% to $2.6 million in 2025.
  • Its Prepaid Assets was $2.6 million in Q3 2025, compared to $3.9 million in Q2 2025 and $4.8 million in Q1 2025.